Literature DB >> 12390023

Reversible ligand-induced dissociation of a tryptophan-shift mutant of phosphofructokinase from Bacillus stearothermophilus.

Michelle R Riley-Lovingshimer1, Donald R Ronning, James C Sacchettini, Gregory D Reinhart.   

Abstract

The biophysical properties of a tryptophan-shifted mutant of phosphofructokinase from Bacillus stearothermophilus (BsPFK) have been examined. The mutant, designated W179Y/Y164W, has kinetic and thermodynamic properties similar to the wild-type enzyme. A 2-fold decrease in kcat is observed, and the mutant displays a 3-fold smaller K(0.5) for the substrate, fructose-6-phosphate (Fru-6-P), as compared to the wild-type enzyme. The dissociation constant for the inhibitor, phospho(enol)pyruvate (PEP), increases 2-fold, and the coupling parameter, Q(ay), decreases 2-fold. This suggests that while the mutant displays a slightly decreased affinity for PEP, PEP is still an effective inhibitor once bound. The new position of the tryptophan in W179Y/Y164W is approximately 6 A from the Fru-6-P portion of the active site. A 25% decrease in fluorescence intensity is observed upon Fru-6-P binding, and an 80% decrease in fluorescence intensity is observed with PEP binding. In addition, the intrinsic fluorescence polarization increases from 0.327 +/- 0.001 to 0.353 +/- 0.001 upon Fru-6-P binding, but decreases to 0.290 +/- 0.001 when PEP binds. Most notably, the presence of PEP induces dissociation of the tetramer. Dissociation of the tetramer into dimers occurs along the active site interface and can be monitored by the loss in activity or the loss in tryptophan fluorescence that is observed when the enzyme is titrated with PEP. Activity can be protected or recovered by incubating the enzyme with Fru-6-P. Recovery of activity is enzyme concentration dependent, and the rate constant for association is 6.2 +/- 0.3 M(-1) x s(-1). Ultracentrifugation experiments revealed that in the absence of PEP the mutant enzyme exists in an equilibrium between the dimer and tetramer forms with a dissociation constant of 11.8 +/- 0.5 microM, while in the presence of PEP the enzyme exists in equilibrium between the dimer and monomer forms with a dissociation constant of 7.5 +/- 0.02 microM. A 3.1 A crystal structure of the mutant enzyme suggests that the amino acid substitutions have not dramatically altered the tertiary structure of the enzyme. While it is clear that wild-type BsPFK exists as a tetramer under these same conditions, these results suggest that quaternary structural changes probably play an important role in allosteric communication.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12390023     DOI: 10.1021/bi0263412

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  In silico work flow for scaffold hopping in Leishmania.

Authors:  Barnali Waugh; Ambarnil Ghosh; Dhananjay Bhattacharyya; Nanda Ghoshal; Rahul Banerjee
Journal:  BMC Res Notes       Date:  2014-11-17

2.  Experimental and simulative dissociation of dimeric Cu,Zn superoxide dismutase doubly mutated at the intersubunit surface.

Authors:  L Maragliano; M Falconi; A Sergi; P Cioni; S Castelli; A Lania; M E Stroppolo; G Strambini; M Ferrario; A Desideri
Journal:  Biophys J       Date:  2005-01-28       Impact factor: 4.033

3.  Effects of protein-ligand associations on the subunit interactions of phosphofructokinase from B. stearothermophilus.

Authors:  R Jason Quinlan; Gregory D Reinhart
Journal:  Biochemistry       Date:  2006-09-26       Impact factor: 3.162

4.  Structure of the apo form of Bacillus stearothermophilus phosphofructokinase.

Authors:  Rockann Mosser; Manchi C M Reddy; John B Bruning; James C Sacchettini; Gregory D Reinhart
Journal:  Biochemistry       Date:  2012-01-11       Impact factor: 3.162

5.  The effect of introducing small cavities on the allosteric inhibition of phosphofructokinase from Bacillus stearothermophilus.

Authors:  Amy M Whitaker; Gregory D Reinhart
Journal:  Arch Biochem Biophys       Date:  2016-07-29       Impact factor: 4.013

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.